What bladder cancer is and how it starts

Bladder cancer begins when cells in the bladder lining grow abnormally and form a tumor. The bladder is a hollow organ that stores urine until your body is ready to release it. Most bladder cancers start in the innermost lining of the bladder wall, called the urothelium or transitional epithelium.

The cancer develops when DNA damage in these cells causes them to divide uncontrollably instead of following the normal cycle of growth and death. This happens over time—usually years—rather than suddenly. In the early stages, the cancer may stay only in the lining. If not caught, it can grow deeper into the muscle layer of the bladder wall or spread to other parts of the body.

Three main types of bladder cancer exist, named after the cell type where the cancer starts. Urothelial carcinoma (also called transitional cell carcinoma) accounts for about 90 percent of cases. Squamous cell carcinoma and adenocarcinoma are less common but often diagnosed at a later stage.

Key Takeaways

  • Bladder cancer starts in the cells lining the bladder and can range from early-stage tumors confined to the lining to advanced cancers that have invaded muscle or spread elsewhere.
  • Blood in the urine is the most common early warning sign, though it can also result from other conditions like urinary tract infections or kidney stones.
  • Risk factors include smoking, age over 55, male sex, chronic bladder irritation, and exposure to certain chemicals in occupational settings.
  • Diagnosis involves a urine test, cystoscopy (a camera inserted into the bladder), and imaging tests to determine how far the cancer has spread.
  • Treatment options depend on the stage and type of cancer and may include surgery, chemotherapy, immunotherapy, or radiation, often used in combination.

Who gets bladder cancer and why

Bladder cancer is more common in people over 55, and men develop it about three times more often than women. However, age and sex are not the only factors that influence risk.

Smoking is the single largest preventable risk factor. Smokers are two to three times more likely to develop bladder cancer than nonsmokers because tobacco smoke contains carcinogens that are filtered through the kidneys and concentrated in the urine, exposing the bladder lining to these chemicals for hours at a time.

Chronic irritation of the bladder also raises risk. People with a history of repeated urinary tract infections, those who use catheters long-term, or those with bladder stones face higher rates. Certain occupational exposures matter too—workers in the chemical, rubber, leather, and textile industries who handle dyes or other chemicals without proper protection have elevated risk.

A personal or family history of bladder cancer, previous cancer treatment (especially radiation to the pelvis or chemotherapy with certain drugs), and some genetic conditions also increase the likelihood. Obesity and diabetes are associated with higher risk as well, though the exact mechanisms are still being studied.

Early signs and symptoms

Blood in the urine is the most common early symptom and often the first sign that prompts someone to see a doctor. The blood may be visible to the naked eye (making urine appear pink, red, or cola-colored) or detected only under a microscope during a routine test. Blood in the urine can come and go, which sometimes delays diagnosis because people assume it resolved on its own.

Other symptoms include pain or burning during urination, urinary urgency (needing to urinate frequently), and urinary frequency (going more often than usual, including at night). These symptoms overlap significantly with urinary tract infections, bladder stones, and other benign conditions, which is why they do not automatically signal cancer. However, when these symptoms persist for more than a few weeks without an obvious cause like infection, they warrant investigation.

Advanced bladder cancer may cause pelvic pain, lower back pain, swelling in the legs or feet, or bone pain if the cancer has spread. By this stage, the cancer has usually grown beyond the bladder itself.

How bladder cancer is diagnosed

Diagnosis typically begins with a urinalysis—a urine sample examined under a microscope to look for blood cells and abnormal cells. If blood or suspicious cells are found, the next step is usually a cystoscopy, a procedure in which a thin, flexible camera (cystoscope) is inserted through the urethra into the bladder so a doctor can see the bladder lining directly and look for tumors or abnormal tissue.

If a tumor is visible during cystoscopy, a biopsy is performed—a small sample of tissue is removed and examined under a microscope to confirm whether cancer is present and, if so, what type and grade it is. The grade describes how abnormal the cells look; higher grades indicate more aggressive cancers.

Once cancer is confirmed, imaging tests determine whether it has spread. These may include a CT scan of the abdomen and pelvis, an MRI, or a chest X-ray to check for spread to the lungs. Some doctors also order a bone scan if there is concern the cancer has reached the bones. These tests together establish the stage of the cancer—how far it has progressed—which guides treatment decisions.

Stages of bladder cancer

Bladder cancer is staged from 0 to IV based on how deeply the tumor has invaded the bladder wall and whether it has spread to lymph nodes or distant organs. Stage 0 cancers are confined to the innermost lining and have not invaded muscle; they are considered non-muscle-invasive. Stages I, II, and III represent progressively deeper invasion into the bladder wall, with stage III reaching the fatty tissue surrounding the bladder. Stage IV means the cancer has spread to nearby organs (such as the prostate, uterus, or colon) or to distant sites like the lungs, liver, or bones.

The distinction between non-muscle-invasive and muscle-invasive cancer is crucial because it determines treatment strategy. Non-muscle-invasive cancers are often treated with surgery alone or surgery plus medication placed directly into the bladder. Muscle-invasive cancers typically require more aggressive treatment, such as chemotherapy, surgery to remove the bladder, or radiation.

Even after successful treatment, bladder cancer can recur—either in the same location or as a new tumor elsewhere in the bladder. This is why follow-up surveillance with regular cystoscopy and urine tests is standard practice for years after initial treatment.

Treatment approaches for bladder cancer

Treatment depends on the stage, grade, and type of cancer, as well as the person's overall health and preferences. For early-stage, non-muscle-invasive cancers, transurethral resection of the bladder tumor (TURBT) is often the first step. During this procedure, a surgeon uses a wire loop passed through the cystoscope to remove the tumor and a margin of surrounding tissue. The tissue is examined to confirm all cancer was removed and to determine the grade.

After TURBT, patients with higher-grade or recurrent tumors often receive intravesical therapy—medication placed directly into the bladder through a catheter. This may be chemotherapy (such as mitomycin C) or immunotherapy (such as BCG, bacillus Calmette-Guérin). These drugs work locally in the bladder to destroy remaining cancer cells and reduce the risk of recurrence.

For muscle-invasive bladder cancer, treatment is more intensive. Radical cystectomy—surgical removal of the bladder, prostate (in men), and uterus and ovaries (in women)—is often recommended, sometimes combined with neoadjuvant chemotherapy (chemotherapy given before surgery to shrink the tumor). Alternatively, some patients may be candidates for bladder-preserving treatment, which combines chemotherapy and radiation therapy to try to keep the bladder intact.

Immunotherapy drugs that help the immune system recognize and attack cancer cells have become increasingly important in recent years, especially for advanced or recurrent cancers. These include checkpoint inhibitors such as pembrolizumab and atezolizumab. Chemotherapy remains a standard option for advanced disease as well.

Life after bladder cancer treatment

Survival rates for bladder cancer vary widely depending on the stage at diagnosis. People diagnosed with early-stage, non-muscle-invasive cancer have much better outcomes than those diagnosed with advanced disease. However, even early-stage cancers require long-term follow-up because recurrence is common.

After treatment, patients typically undergo regular cystoscopy and urine tests for at least five years, and often longer. The frequency depends on the initial stage and grade of the cancer. Some people may need surveillance for life. This ongoing monitoring can catch recurrences early, when they are most treatable.

Side effects of treatment vary. Surgery to remove the bladder requires creation of a new way for urine to leave the body—either an external pouch worn on the skin (urostomy) or a surgically constructed internal reservoir (neobladder). Chemotherapy and radiation can cause fatigue, nausea, and other effects during and after treatment. Immunotherapy may trigger autoimmune reactions. A healthcare team can discuss what to expect and how to manage side effects.

Frequently Asked Questions

Does blood in the urine always mean bladder cancer?

No. Blood in the urine has many causes, including urinary tract infections, kidney stones, enlarged prostate, and bleeding disorders. However, any blood in the urine that persists or recurs should be evaluated by a doctor to rule out cancer and identify the actual cause.

Can bladder cancer be prevented?

Not completely, but risk can be reduced. The most important step is not smoking or quitting if you do smoke. Staying hydrated, limiting exposure to occupational chemicals, and treating chronic urinary tract infections promptly may also help lower risk, though the evidence is strongest for smoking cessation.

What is the difference between non-muscle-invasive and muscle-invasive bladder cancer?

Non-muscle-invasive cancer is confined to the inner lining of the bladder and is often treated with surgery alone or surgery plus medication in the bladder. Muscle-invasive cancer has grown into or through the muscle layer and typically requires more aggressive treatment, such as chemotherapy, bladder removal, or radiation.

If my bladder is removed, how will I urinate?

A surgeon creates an alternative way for urine to leave your body. Common options include a urostomy (an opening in the abdomen where urine drains into an external pouch you wear), or a neobladder (a surgically constructed reservoir made from part of your small intestine that functions like a bladder). Your surgical team will discuss which option is best for your situation.

How often do people need follow-up care after bladder cancer treatment?

Follow-up schedules vary based on the initial stage and grade of cancer. Most people have cystoscopy and urine tests every three months for the first year or two, then less frequently if no recurrence is found. Some people may need surveillance for life. Your doctor will recommend a schedule tailored to your specific situation.